GO:0006164 purine nucleotide biosynthetic process: De Novo and Salvage Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006164 describes the chemical reactions and pathways that build purine nucleotides, the building blocks of DNA and RNA, from simpler precursors.
• Purine nucleotides are synthesized by two complementary routes: the de novo pathway, which assembles the purine ring from small molecules, and the salvage pathway, which recycles free purine bases.
• The de novo pathway is energetically expensive and requires folate-derived one-carbon units, linking it to serine, glycine, and methionine metabolism.
• Tumors and activated immune cells often depend on de novo purine synthesis, making this pathway a target for cancer and immunometabolism research.
• The purine nucleotide cycle interconverts AMP, IMP, and fumarate and is important for energy sensing and muscle metabolism.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of purine biosynthetic genes in disease and development.
Description
Purine nucleotides are essential for life: they are the monomeric units of DNA and RNA, the energy carriers ATP and GTP, and the signaling molecules cAMP and cGMP. The Gene Ontology term GO:0006164, purine nucleotide biosynthetic process, captures the chemical reactions and pathways that result in the formation of a purine nucleotide, defined as a purine base linked to a ribose or deoxyribose sugar and esterified with a phosphate group at the 3' or 5'-hydroxyl group. This term is central to metabolism because it unites the de novo pathway, which builds the purine ring atom by atom, and the salvage pathway, which recycles preformed bases. Researchers study GO:0006164 because its output, purine nucleotides, controls cell proliferation, differentiation, and survival. Rapidly dividing cells such as tumor cells and activated T cells must sustain high purine flux, and they often shift between de novo synthesis and salvage depending on tissue context and nutrient availability. The pathway is also intimately connected to folate and one-carbon metabolism, so its activity reports on the broader metabolic state of a cell. From a disease perspective, dysregulated purine nucleotide biosynthesis contributes to cancer, immune disorders, myocardial ischemia-reperfusion injury, and developmental defects in plants and animals. Understanding which genes drive flux through this pathway, and how they are regulated, is therefore a major goal of metabolic research. This article summarizes the authoritative GO definition, the major enzymatic steps, the key genes, and the experimental models used to interrogate purine nucleotide biosynthetic process.
purine nucleotide biosynthetic process At A Glance
| GO ID | GO:0006164 |
|---|---|
| GO term | purine nucleotide biosynthetic process |
| Ontology | biological_process |
| Definition | The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of a nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar. |
| Synonyms | purine nucleotide anabolism; purine nucleotide biosynthesis; purine nucleotide formation; purine nucleotide synthesis |
| Major function | Production of AMP, GMP, IMP, and related purine nucleotides for DNA, RNA, ATP, GTP, and signaling molecules |
| Pathway routes | De novo purine synthesis and salvage purine synthesis |
| Key cofactor link | Folate-dependent one-carbon metabolism supplies formyl groups for the de novo pathway |
| Disease relevance | Cancer, immune activation, myocardial ischemia-reperfusion injury, and developmental disorders |
What Is GO:0006164?
GO:0006164 purine nucleotide biosynthetic process is the set of chemical reactions and pathways that lead to the formation of a purine nucleotide. A purine nucleotide consists of a purine base (adenine or guanine) attached to a ribose or deoxyribose sugar, with a phosphate group esterified at the 3' or 5'-hydroxyl group of the sugar. The term includes both de novo synthesis, in which the purine ring is assembled from simple precursors such as amino acids and one-carbon units, and salvage reactions that convert free purine bases or nucleosides into nucleotides.
Why Is purine nucleotide biosynthetic process Important in Cell Biology?
Purine nucleotide biosynthetic process is important because it supplies the nucleotides required for genome replication, transcription, energy transfer, and signal transduction. Without adequate purine nucleotide synthesis, cells cannot divide or maintain RNA and DNA integrity. The pathway is also a metabolic hub that integrates amino acid, folate, and one-carbon metabolism, so its activity reflects the nutritional and biosynthetic state of a cell. In disease, tumor cells and activated immune cells frequently upregulate de novo purine synthesis to support proliferation, while ischemia-reperfusion injury can be mitigated by purine nucleotide precursors. Consequently, genes in GO:0006164 are candidate biomarkers and therapeutic targets across oncology, immunology, and cardiovascular biology.
• Provides AMP and GMP for RNA and DNA synthesis, and for ATP and GTP energy currency.
• Supports rapid proliferation of tumor cells and activated effector T cells.
• Links to folate and one-carbon metabolism through formyl-group donation.
• The purine nucleotide cycle interconverts AMP, IMP, and fumarate to buffer energy charge.
• Purine nucleotide precursors can protect the heart from ischemia-reperfusion injury.
• Mitochondrial folate metabolism and purine sensing influence cell differentiation via mTORC1.
• Purine biosynthetic genes such as GARS control chloroplast development in rice.
• FAMIN is a multifunctional purine enzyme enabling the purine nucleotide cycle in immune cells.
• Dysregulation of purine synthesis is associated with cancer, immune disorders, and developmental defects.
• The pathway is a target for antimetabolite drugs and metabolic inhibitors in research and therapy.
What Happens During purine nucleotide biosynthetic process?
De novo purine synthesis: building the purine ring
In simple terms: Cells build the purine ring from scratch using small molecules like amino acids and formyl groups.
The de novo pathway assembles the purine ring on ribose-5-phosphate through a series of enzymatic steps. It consumes glycine, glutamine, aspartate, and formyl groups derived from folate metabolism, and it requires ATP. The pathway produces inosine monophosphate (IMP), the first fully formed purine nucleotide, which is then converted to AMP and GMP. Because de novo synthesis is energetically expensive, cells often rely on it only when salvage cannot meet demand, such as during rapid proliferation.
Salvage purine synthesis: recycling preformed bases
In simple terms: Instead of building from scratch, cells can recycle free purine bases back into nucleotides.
The salvage pathway converts free purine bases such as adenine, guanine, and hypoxanthine into their corresponding nucleotides using phosphoribosyltransferases. This route is energetically cheaper than de novo synthesis and is often the dominant source of purine nucleotides in non-proliferating tissues. Tumors and activated immune cells can switch between de novo and salvage routes depending on tissue context and nutrient availability, and this flexibility is a key area of metabolic research.
The purine nucleotide cycle: interconverting AMP, IMP, and fumarate
In simple terms: A cycle of reactions interconverts AMP and IMP while releasing fumarate, helping cells manage energy.
The purine nucleotide cycle links purine metabolism to the tricarboxylic acid cycle through the interconversion of AMP, IMP, and fumarate. This cycle is important for energy sensing and is especially active in muscle and immune cells. FAMIN is a multifunctional purine enzyme that enables the purine nucleotide cycle, and its activity influences immune cell function.
Folate and one-carbon input into purine synthesis
In simple terms: Folate metabolism supplies the one-carbon units needed to build purines.
Folate-dependent one-carbon metabolism provides formyl groups for the de novo purine pathway. Serine is a major one-carbon donor, and its metabolism is essential for effector T cell expansion because it supports purine nucleotide biosynthesis. Inhibition of mitochondrial folate metabolism can drive differentiation through mTORC1-mediated purine sensing, showing that purine nucleotide levels are monitored by growth-signaling pathways.
Tissue-specific use of de novo versus salvage pathways
In simple terms: Different tissues prefer different routes to make purines, and tumors can adapt.
Recent work has mapped de novo and salvage purine synthesis across normal tissues and tumors, revealing tissue-specific preferences and tumor adaptations. This heterogeneity means that the contribution of GO:0006164 to a given cell type cannot be assumed and must be measured experimentally. Such measurements are important for designing metabolic therapies that target purine synthesis selectively.
Key Genes Involved in GO:0006164 purine nucleotide biosynthetic process
The following genes and proteins are experimentally implicated in purine nucleotide biosynthetic process and its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPAT | Catalyzes the first committed step of de novo purine synthesis | Target for metabolic inhibition and flux studies |
| GART | Trifunctional enzyme in de novo purine synthesis | Model for pathway enzymology and inhibitor testing |
| PFAS | Formylglycinamidine ribonucleotide synthase in de novo pathway | Studied in purine flux and tumor metabolism |
| PAICS | Bifunctional enzyme in IMP synthesis | Candidate target in cancer metabolism |
| ATIC | Bifunctional enzyme in IMP synthesis | Linked to purine nucleotide cycle and disease |
| IMPDH1 | Converts IMP to GMP | Target of immunosuppressive and antiviral drugs |
| IMPDH2 | Converts IMP to GMP | Studied in cancer and immune cell proliferation |
| GMPS | Converts xanthosine monophosphate to GMP | Relevant to guanine nucleotide supply |
| ADSS1 | Converts IMP to adenylosuccinate in AMP synthesis | Model for AMP synthesis and muscle metabolism |
| ADSL | Cleaves adenylosuccinate to AMP and fumarate | Linked to purine nucleotide cycle and neurodevelopment |
| HPRT1 | Salvage enzyme converting hypoxanthine to IMP | Classic gene in purine salvage and Lesch-Nyhan research |
| APRT | Salvage enzyme converting adenine to AMP | Model for adenine salvage and kidney disease |
| FAMIN | Multifunctional purine enzyme enabling the purine nucleotide cycle | Immune cell metabolism and inflammation |
| GARS | Purine nucleotide biosynthetic gene controlling chloroplast development | Plant development and chloroplast biogenesis |
| MTHFD2 | Mitochondrial folate enzyme supporting purine synthesis | Differentiation and mTORC1 purine sensing |
| SHMT1 | Serine hydroxymethyltransferase contributing one-carbon units | Effector T cell expansion and purine supply |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase | One-carbon metabolism and purine synthesis |
How Is purine nucleotide biosynthetic process Regulated?
Purine nucleotide biosynthetic process is regulated at multiple levels. Growth-signaling pathways such as mTORC1 sense purine nucleotide availability, and inhibition of mitochondrial folate metabolism can drive differentiation through mTORC1-mediated purine sensing. Serine metabolism supplies one-carbon units that are essential for effector T cell expansion, linking nutrient availability to purine synthesis. The purine nucleotide cycle, enabled by FAMIN, interconverts AMP, IMP, and fumarate and contributes to energy sensing and immune cell function. In addition, tissue-specific differences in de novo versus salvage pathway use indicate that transcriptional and metabolic regulation fine-tunes flux through GO:0006164.
purine nucleotide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPAT | Cancer cell proliferation | Knockout in cancer cell lines followed by proliferation assay |
| ATIC | Purine nucleotide cycle and immune function | Point-mutation knock-in to test enzyme activity |
| FAMIN | Immune cell metabolism and inflammation | Knockout in immune cells with metabolic flux analysis |
| MTHFD2 | Differentiation and mTORC1 purine sensing | Inducible knockout with differentiation readout |
| GARS | Chloroplast development in rice | Plant knockout and developmental phenotyping |
Cancer metabolism and purine dependency
Many tumors depend on de novo purine synthesis to support rapid proliferation, and mapping of de novo and salvage pathways across tumors has revealed tissue-specific dependencies. This has made purine biosynthetic enzymes attractive targets for metabolic therapy, and CRISPR models are used to test whether individual genes are required for tumor growth.
Immune cell activation and inflammation
Effector T cell expansion requires serine-dependent one-carbon metabolism to support purine nucleotide biosynthesis, and FAMIN enables the purine nucleotide cycle in immune cells. Dysregulation of these pathways can contribute to inflammatory and autoimmune conditions, making purine enzymes candidate therapeutic targets.
Myocardial ischemia-reperfusion injury
Purine nucleotide precursors have been studied for their ability to prevent myocardial ischemia-reperfusion injury, highlighting the clinical relevance of purine nucleotide availability in the heart. This work connects GO:0006164 to cardioprotection and energy metabolism under stress.
Developmental and plant biology
The purine nucleotide biosynthetic gene GARS controls early chloroplast development in rice, demonstrating that this pathway is essential beyond human disease contexts. Such findings show the deep evolutionary conservation of purine nucleotide biosynthesis and its role in development.
From purine nucleotide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a purine biosynthetic gene essential for proliferation? | CRISPR knockout in cancer cell lines |
| Does a specific enzyme mutation alter purine flux? | Point-mutation knock-in with metabolic labeling |
| Can a tagged enzyme be used to map pathway localization? | Tagged knock-in with imaging and proteomics |
| Does overexpression of a salvage enzyme rescue de novo defects? | Overexpression cell model with rescue assay |
| How does folate metabolism regulate purine synthesis? | Knockout of MTHFD2 or SHMT2 with mTORC1 readout |
| What is the role of purine synthesis in immune activation? | Knockout in primary T cells with expansion assay |
How to Study the purine nucleotide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Stable isotope tracing | Flux through de novo and salvage purine pathways | Tissue and tumor metabolic mapping |
| LC-MS metabolomics | Levels of AMP, GMP, IMP, and intermediates | Validation of genetic perturbations |
| RNA-seq | Expression of purine biosynthetic genes | Tissue-specific pathway profiling |
| Proteomics | Protein abundance of pathway enzymes | Identifying regulatory changes |
| CRISPR knockout screens | Gene essentiality for purine synthesis | Functional genomics discovery |
| Metabolic labeling with serine | One-carbon contribution to purines | Immune cell expansion studies |
| mTORC1 activity assays | Purine sensing and downstream signaling | Differentiation and growth studies |
| Plant developmental phenotyping | Chloroplast and growth defects | GARS function in rice |
Metabolic flux analysis with stable isotopes
Stable isotope tracing using labeled precursors such as glycine, serine, or formate allows researchers to measure flux through de novo and salvage purine pathways. This approach has been used to map purine synthesis across tissues and tumors.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for purine nucleotide biosynthesis and for proliferation under specific metabolic conditions. Such screens help prioritize candidate genes within GO:0006164 for deeper study.
Transcriptomics and proteomics
RNA-seq and proteomics measure expression of purine biosynthetic enzymes and can reveal tissue-specific or disease-specific rewiring. These methods complement flux measurements and help identify regulatory nodes.
Targeted metabolite quantification
Liquid chromatography-mass spectrometry can quantify purine nucleotides such as AMP, GMP, and IMP directly. This is essential for validating genetic or pharmacological perturbations of the pathway.
How CRISPR Can Be Used to Study GO:0006164 purine nucleotide biosynthetic process
Knockout
CRISPR knockout of purine biosynthetic genes such as PPAT, GART, or PAICS can test whether they are essential for proliferation or survival in a given cell type. Knockout models are widely used to validate metabolic dependencies identified in screens.
Point Mutation
Point-mutation knock-in can be used to dissect catalytic residues or regulatory phosphorylation sites in purine enzymes. This approach helps distinguish enzyme activity from scaffolding functions and can model disease-associated variants.
Knock-in
Tagged knock-in of purine enzymes enables localization, interaction, and degradation studies. Knock-in of reporter or affinity tags supports imaging and proteomic analysis of the pathway in native context.
Overexpression
Overexpression of salvage enzymes such as HPRT1 or APRT can test whether increased salvage flux rescues defects in de novo synthesis. Overexpression models are also useful for studying pathway competition and metabolic flexibility.
How EDITGENE Supports purine nucleotide biosynthetic process Research
Researchers studying purine nucleotide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway flux, cell proliferation, or disease phenotypes. CRISPR-based models provide a direct way to test causality by introducing precise genetic perturbations and measuring the resulting metabolic and phenotypic changes.
Contact EDITGENE today to design your custom CRISPR model for purine nucleotide biosynthetic process research.
Frequently Asked Questions About purine nucleotide biosynthetic process
What is GO:0006164 purine nucleotide biosynthetic process?
GO:0006164 is a Gene Ontology biological process term describing the chemical reactions and pathways that form a purine nucleotide, including de novo synthesis and salvage routes.
What genes are involved in purine nucleotide biosynthetic process?
Key genes include PPAT, GART, PFAS, PAICS, ATIC, IMPDH1, IMPDH2, GMPS, ADSS1, ADSL, HPRT1, APRT, FAMIN, GARS, MTHFD2, SHMT1, and SHMT2.
Why is purine nucleotide biosynthesis important for cancer?
Many tumors depend on de novo purine synthesis to support rapid proliferation, making pathway enzymes candidate therapeutic targets.
How is purine nucleotide biosynthesis linked to folate metabolism?
Folate-dependent one-carbon metabolism supplies formyl groups for the de novo pathway, and serine is a major one-carbon donor.
What is the purine nucleotide cycle?
The purine nucleotide cycle interconverts AMP, IMP, and fumarate and is important for energy sensing, especially in muscle and immune cells.
Can purine nucleotide precursors protect the heart?
Purine nucleotide precursors have been studied for preventing myocardial ischemia-reperfusion injury, suggesting a cardioprotective role.
How do researchers study purine nucleotide biosynthetic process?
Common methods include stable isotope tracing, LC-MS metabolomics, RNA-seq, proteomics, and CRISPR knockout screens.
What CRISPR models are used for purine pathway genes?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression models are used to test gene function and causality.
Is purine nucleotide biosynthesis important in immune cells?
Yes, effector T cell expansion requires serine-dependent one-carbon metabolism for purine synthesis, and FAMIN enables the purine nucleotide cycle in immune cells.
Does purine nucleotide biosynthesis occur in plants?
Yes, the purine nucleotide biosynthetic gene GARS controls early chloroplast development in rice, showing conservation of the pathway.
Conclusion
GO:0006164 purine nucleotide biosynthetic process is a central metabolic pathway that supplies the nucleotides needed for DNA, RNA, energy transfer, and signaling. Its dual de novo and salvage routes, its integration with folate and one-carbon metabolism, and its tissue-specific regulation make it a rich area for research in cancer, immunology, cardiology, and development. CRISPR-based models and metabolic profiling methods now allow precise causal testing of pathway genes, and services such as those offered by EDITGENE support these efforts. Understanding how purine nucleotide biosynthesis is rewired in disease will continue to reveal new therapeutic opportunities.
References
- 1. Tran DH et al.. 2024. De novo and salvage purine synthesis pathways across tissues and tumors.. Cell 187(14):3602-3618.e20 PMID: 38823389
- 2. Cader MZ et al.. 2020. FAMIN Is a Multifunctional Purine Enzyme Enabling the Purine Nucleotide Cycle.. Cell 180(2):278-295.e23 PMID: 31978345
- 3. Ma EH et al.. 2017. Serine Is an Essential Metabolite for Effector T Cell Expansion.. Cell Metab 25(2):345-357 PMID: 28111214
- 4. Musial PT et al.. 2025. Purine Nucleotide Precursors in Preventing Myocardial Ischemia-Reperfusion Injury.. Int J Mol Sci 26(21) PMID: 41226492
- 5. Zarou MM et al.. 2024. Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing.. Nat Commun 15(1):1931 PMID: 38431691
- 6. Cao P et al.. 2019. Purine nucleotide biosynthetic gene GARS controls early chloroplast development in rice (Oryza sativa L.).. Plant Cell Rep 38(2):183-194 PMID: 30499032
- 7. Lowenstein JM. 1990. The purine nucleotide cycle revisited [corrected].. Int J Sports Med 11 Suppl 2:S37-46 PMID: 2193892
- 8. Baggott JE et al.. 2015. Folate-Dependent Purine Nucleotide Biosynthesis in Humans.. Adv Nutr 6(5):564-71 PMID: 26374178
